Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Chinese patients with alopecia areata value JAK inhibitors but worry about side effects and relapse, highlighting the need for education and support.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Dermatologists are hesitant to prescribe Janus kinase inhibitors for alopecia areata due to safety concerns and lack of knowledge.

Ritlecitinib is more effective and cheaper than baricitinib for treating severe alopecia areata.

Ritlecitinib effectively regrows hair in treatment-resistant alopecia areata with mild side effects.

Switching Janus kinase inhibitors helped some patients with severe alopecia areata regrow hair, but insurance issues can worsen the condition.

The inhibitor affects androgen metabolism but not ovarian function.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

Stopping TNFα inhibitors can help children regrow hair lost due to the medication.

A woman's hair turned white after taking a cancer drug called dasatinib.

Tianeptine may help prevent hair loss by promoting hair growth and reducing cell death.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Janus Kinase inhibitors are effective and safe for treating alopecia areata, but more research is needed.

Experts created guidelines for who in Australia can get subsidized JAK inhibitor therapy for alopecia areata.

Tribuloside can increase skin pigmentation by enhancing melanin production and distribution.

Tofacitinib effectively promotes hair regrowth in children with alopecia areata, but more research on long-term safety is needed.

Rapamycin may help treat Leigh syndrome by targeting protein kinase C.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

Blocking interferon-gamma might help treat various autoimmune diseases.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

New treatments like JAK inhibitors offer hope for better alopecia areata management.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

Yiqi Huayu medicine can effectively reduce BPH in rats by lowering MMP-2 levels and blood vessel growth.

Tofacitinib may effectively treat folliculitis decalvans.

Matriptase-2 helps control iron levels by suppressing hepcidin, and its deficiency can cause iron-deficiency anemia.

Tofacitinib may cause nerve damage in the brain, so monitor for neurological symptoms.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.